Roundtable Meet the Expert track
MTE #2: New Frontiers in Targeting Alcohol Use and Liver Disease—Fibroblast Growth Factor 21 and Glucagon-like Peptide-1 Receptor Agonists (Ticketed)
Fri, Nov 6, 2026 · 7:00–7:45 AM MST Convention Center: Room 1B, Colorado Convention Center
About this session
Join topic experts for this intriguing session that explores the emerging therapeutic landscape for treating alcohol use disorder (AUD) and alcohol-associated liver disease (ALD). Speakers focus specifically on fibroblast growth factor 21 (FGF21) and glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in the context of AUD and ALD. Presenters also explore future translational research questions involving FGF21 and GLP-1 RAs.
Speakers
-
University of California San Diego
Facilitator
Reviews of this session
No reviews yet
Were you in the room? Reviews are open until Nov 9, 2027.